Why bank your child’s cord blood at Cryosite?
Cryosite is the industry leader with an exceptional reputation and at this precious time we are committed to ensuring that your cord blood banking experience is as easy as possible, from your initial enquiry right through to the safe storage of your baby’s cord blood
Proven expertise – when you are making such an important decision as saving your baby’s cord blood, it is vital that you know about the company that you are dealing with. Cryosite is a publicly-listed Australian company, established in 2000 to provide specialist ultra-low temperature and cryogenic storage services to a wide range of clients including the research, medical, pharmaceutical and biotechnology industries. The cord blood service was established in 2001 and its cord blood laboratories and cryogenic storage facilities are fully licensed by the Therapeutic Goods Administration (TGA) of Australia.
We own our lab – other companies operating in Australia sub-contract out the critical tasks of processing and storage to third parties, so you may not know what will happen to your sample when the contract between the lab and the company expires. Unlike other companies, Cryosite has its own highly secure laboratories, dedicated to processing, cryopreserving and storing cord blood stem cells. Our comprehensive service includes processing and storage onsite where we have multiple levels of backup in place to safeguard the integrity of your baby’s cord blood.
Cryosite is the only private cord blood service in Australia to own and operate fully licensed cord blood bank laboratories.
Our people – because Cryosite owns and operates its own stem cell laboratories and cryogenic storage facility, we attract and employ highly experienced stem cell scientists and quality assurance, regulatory affairs and cryogenic storage professionals. Our expertise cannot be matched by other cord blood companies who contract out these services to third parties.
Regulatory compliance – when choosing a company to look after something as precious as your baby’s cord blood stem cells you need to ensure that the company is properly accredited. Cryosite’s facility, including its cord blood laboratories and cryogenic storage facilities, are fully licensed by the Therapeutic Goods Administration (TGA) for the manufacture, storage and release of autologous cord blood stem cells. Our diversified biotech services business model provides our clients with financial and corporate security into the future.
Industry leader – Cryosite continues to grow. Thousands of parents have placed their trust in us by storing their baby’s cord blood stem cells and our diversified biotech services business model provides our clients with financial and corporate security. To date, more than 600 obstetricians have participated in collecting cord blood for our clients at more than 250 hospitals and birthing centers throughout Australia, New Zealand, Hong Kong, Singapore, New Caledonia and Japan. We routinely collect cord blood from every state in Australia.
Corporate Strength – Cryosite is an Australian public listed company providing specialised services to a wide range of clients including the research, medical, pharmaceutical and biotechnology industries. The range of services provided includes:
- Private Cord blood Service
- Clinical Trial Logistics
- Archival Storage of biological samples
- Adult Stem Cell Storage (through a relationship with the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne)
- Exclusive ATCC Distributor for Australia and New Zealand
As a successful public listed company, we continue to attract new clients across all business sectors and confidently predict that the business will continue to enjoy significant growth during the next financial year. Our strong customer focus allows us to respond quickly and efficiently to emerging requirements and meet the growing needs of the marketplace while our ongoing commitment to quality has allowed us to attract and develop relationships with the Peter Mac and other blue-chip pharmaceutical companies such as Pfizer (Australia) Pty, Bristol-Myers Squibb Pty Ltd, Schering-Plough and Janssen-Cilag.
Security – is a critical consideration when entrusting a company to manage the long-term storage of your cord blood stem cells. Your cord blood company must demonstrate they understand, and have control over, their facilities, cryogenic storage vessels and manufacturing laboratories. Cryosite has developed a state-of-the-art facility with sophisticated monitoring and control systems and multiple levels of back up. To ensure the security of your child’s cord blood:
- The facility is secured with strictly controlled smart card access entry, CCTV and back-to-base intrusion alarms. Audit trails track access to the facility and storage units.
- Liquid nitrogen storage units are fitted with automated management systems and are individually monitored 24hrs a day with alarms directed to a 24 x 7 manned security facility. Cryosite staff respond around the clock.
- The facility is temperature and humidity controlled and critical operations are performed in clean rooms.
- The facility has an independent switchboard, UPS power supplies and a 440kva back up diesel generator to enable the entire facility to operate continuously independently from the power grid.
